Back
Biomarin Pharmaceutical Stock Predictions
Sponsored
BMRN
Sponsored
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!
Buy
54
BMRN
Biomarin Pharmaceutical
Last Price:
66.06
Seasonality Move:
13.3%
7 Day Trial
ALL ACCESS PASS
$
7
Write This Down: Tuesday at 2 p.m. ET!
Don't Miss Our LIVE TradeBiomarin Pharmaceutical Stock Forecast
- Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 12.9% based on the past 25 years of stock performance.
- Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Biomarin Pharmaceutical Stock Undervalued?
The current Biomarin Pharmaceutical [BMRN] share price is $66.04. The Score for BMRN is 54, which is 8% above its historic median score of 50, and infers lower risk than normal. - BMRN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Biomarin Pharmaceutical Stock Go Up Next Year?
- Over the next 52 weeks, Biomarin Pharmaceutical has on average historically risen by 12.9% based on the past 25 years of stock performance.
Biomarin Pharmaceutical Stock Rating
Buy
54
Biomarin Pharmaceutical (BMRN)
is a Buy
Is Biomarin Pharmaceutical overpriced?
- Biomarin Pharmaceutical has risen higher in 15 of those 25 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Biomarin Pharmaceutical Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
biomarin.com
52-Week Data
52-Week High:
99.56
52-Week Low:
65.35
Prediction Charts
Market Cap:
12.59B
Price in USD:
66.04
Volume:
1.61M
Beta:
0.88
Technical Analysis
SMA50:
74.56
SMA100:
80.05
SMA200:
82.71
52-Wk Change:
-17.02%
Stock Predictions
-
Is Biomarin Pharmaceutical stock public?
Yes, Biomarin Pharmaceutical is a publicly traded company. -
What is the Biomarin Pharmaceutical stock quote today?
The Biomarin Pharmaceutical stock price is 66.04 USD today. -
How to buy Biomarin Pharmaceutical stock online?
You can buy Biomarin Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-16 | 70.24 | 70.16 | 70.90 | 69.94 |
Oct-18 | 69.70 | 70.11 | 70.13 | 69.29 |
Oct-21 | 69.99 | 70.28 | 70.81 | 69.56 |
Oct-22 | 69.72 | 70.53 | 70.74 | 69.50 |
Oct-23 | 70.23 | 69.98 | 70.37 | 69.40 |
Oct-24 | 70.05 | 70.39 | 70.98 | 69.58 |
Oct-25 | 70.68 | 69.73 | 70.98 | 69.66 |
Oct-28 | 69.92 | 70.13 | 70.71 | 69.60 |
Oct-29 | 69.78 | 69.92 | 70.56 | 69.20 |
Oct-30 | 69.67 | 66.68 | 69.67 | 65.78 |
Oct-31 | 66.68 | 65.87 | 66.92 | 65.35 |
Nov-1 | 65.70 | 66.60 | 66.81 | 65.60 |
Nov-4 | 66.24 | 66.00 | 66.59 | 65.56 |
Nov-5 | 66.23 | 66.04 | 66.23 | 65.45 |
Biomarin Pharmaceutical Earnings
Biomarin Pharmaceutical Earnings Report: Per Share Biomarin Pharmaceutical Earnings Q1 Q2 Q3 and Q4 last year and next year.
Biomarin Pharmaceutical Forecast Revenue Growth
Biomarin Pharmaceutical Stock Analysis: Historical quarterly revenues per share for Biomarin Pharmaceutical and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.25 per share, and an increase next year of $0.80 per share.
* Biomarin Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.